Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria
Clinical trial NCT03580044 · TERMINATED
Trial details
- NCT number
- NCT03580044
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-25
- Primary completion
- 2023-01-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.